Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U1 small nuclear 5, pseudogene (RNU1-5P) is a pseudogene that corresponds to the U1 small nuclear RNA (snRNA) gene family, specifically a non-functional copy of the U1 snRNA gene[1][3]. U1 snRNA itself is a critical component of the U1 small nuclear ribonucleoprotein complex, which is essential for pre-mRNA splicing in the spliceosome[2][4]. However, pseudogenes such as RNU1-5P are typically not transcribed into functional RNA or protein products and are considered genomic relics with no known direct biological or therapeutic role[1][3]. RNU1-5P does not encode a receptor, enzyme, or any protein, and it is not considered a therapeutic target. The presence of "pseudogene" in its name, and confirmation from genetic databases, indicates that this locus does not produce active or functional RNA with a characterized biological function[1][3]. Some U1 snRNA pseudogenes may be transcribed at very low levels or contribute to regulatory non-coding RNA pools, but there is no evidence for such a role for RNU1-5P at this time. Notes: - This entry is likely incorrect as a therapeutic target since pseudogenes are not drug targets and this specific pseudogene lacks known function or role in disease[1][3]. - The confusion may arise from conflating the functional U1 snRNA genes (which play key roles in splicing) with non-functional pseudogenes like RNU1-5P. - The correct molecular classification is pseudogene, which falls under "other" or "non-coding RNA" categories, not a receptor, enzyme, or classic drug target.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 5, pseudogene (RNU1-5P).